China SXT Pharmaceuticals (SXTC) Debt Ratio: 2019-2025

  • China SXT Pharmaceuticals' Debt Ratio fell 98.40% to 0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year increase of 7.98%. This contributed to the annual value of 0.04 for FY2025, which is 39.69% up from last year.
  • According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Debt Ratio is 0.00, which was down 89.44% from 0.04 recorded in Q1 2025.
  • China SXT Pharmaceuticals' 5-year Debt Ratio high stood at 0.35 for Q1 2021, and its period low was 0.00 during Q1 2022.
  • Over the past 3 years, China SXT Pharmaceuticals' median Debt Ratio value was 0.03 (recorded in 2023), while the average stood at 0.06.
  • In the last 5 years, China SXT Pharmaceuticals' Debt Ratio surged by 14,661.97% in 2021 and then plummeted by 99.90% in 2022.
  • Over the past 5 years, China SXT Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.09 in 2021, then crashed by 41.79% to 0.05 in 2022, then plummeted by 36.54% to 0.03 in 2023, then spiked by 605.53% to 0.24 in 2024, then crashed by 98.40% to 0.00 in 2025.
  • Its Debt Ratio stands at 0.00 for Q3 2025, versus 0.04 for Q1 2025 and 0.24 for Q3 2024.